| Literature DB >> 32649566 |
Ahmad Al Omari1, Ra'ed Al-Ashqar1, Amjad Nuseir1, Hassan Al Balas2, Hadeel Allan3, Yazan Kanaan1, Firas Alzoubi1.
Abstract
At the end of December, 2019, a new virus was named severe acute respiratory syndrome coronavirus 2 appeared in Wuhan, China, and the disease caused is called as coronavirus disease 2019 (COVID-19) by World Health Organization, which to date having infected more than 3,588,773 people worldwide, as well as causing 247,503 deaths. A human to human transmission is thought to be predominantly by droplet spread, and direct contact with the patient or contaminated surfaces. This study aims to provide a comprehensive overview as well as to highlight essential evidence-based guidelines for how head and neck surgeon and healthcare providers need to take into consideration during their management of the upper airway during the COVID-19 pandemic safely and effectively to avoid the spread of the virus to the health provider.Entities:
Mesh:
Year: 2020 PMID: 32649566 PMCID: PMC7382411 DOI: 10.1097/SCS.0000000000006798
Source DB: PubMed Journal: J Craniofac Surg ISSN: 1049-2275 Impact factor: 1.172